Treatment of leukaemias and reticuloses with uracil mustard.
D002283:Carcinoma, Bronchogenic; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008223:Lymphoma; D008224:Lymphoma, Follicular; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms; D009588:Nitrogen Mustard Compounds; D020135:Peptide Nucleic Acids; D011087:Polycythemia Vera; D012509:Sarcoma; D014499:Uracil Mustard
D009588:Nitrogen Mustard Compounds; D020135:Peptide Nucleic Acids; D014499:Uracil Mustard
CARCINOMA, BRONCHOGENIC; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; LYMPHOMA; LYMPHOMA, GIANT FOLLICULAR; NITROGEN MUSTARD COMPOUNDS; POLYCYTHEMIA VERA; SARCOMA, RETICULUM CELL